Objective: The purpose of this study was to evaluate the immediate effects of upper cervical translatoric spinal mobilization (UC-TSM) on cervical mobility and pressure pain threshold in subjects with cervicogenic headache (CEH). Methods: Eighty-two volunteers (41.54 ± 15.29 years, 20 male and 62 female) with CEH participated in the study and were randomly divided into the control and treatment groups. The treatment group received UC-TSM and the control group remained in the same position for the same time as the UC-TSM group, but received no treatment. Cervical mobility (active cervical mobility and flexion-rotation test), pressure pain thresholds over upper trapezius muscles, C2-3 zygapophyseal joints and suboccipital muscles, and current headache intensity (visual analog scale) were measured before and immediately after the intervention by 2 blinded investigators. Results: After the intervention, UC-TSM group exhibited significant increases in total cervical mobility (P = .002, d = 0.16) and the flexion-rotation test (P b .001, d = 0.81-0.85). No significant difference in cervical pressure pain thresholds were observed between groups (P N .05). Nevertheless, there was a significantly lower intensity of headache in the UC-TSM group (P = .039, d = 0.57). Conclusions: Upper cervical translatoric spinal mobilization intervention increased upper, and exhibited a tendency to improve general, cervical range of motion and induce immediate headache relief in subjects with CEH. (J Manipulative Physiol Ther 2017;40:649-658) 
INTRODUCTION
Cervicogenic headache (CEH), a secondary headache arising from cervical disorders, is today internationally recognized as a distinct clinical entity. 1 However, for many years, there has been international disagreement on the acceptance of this condition. 2 In 1860, Hilton was the first to describe the concept of a headache that originates in the cervical region, but it was not until 1983 when Sjaastad coined the term "cervicogenic headache." 3 Cervicogenic headache is characterized by unilateral headache with symptoms and signs of neck involvement, including impairment in cervical range of motion (CROM) and pain on palpation of the neck, especially on the upper cervical spine. 4 Restoration of the upper cervical mobility is usually considered 1 of the main objectives for the treatment of CEH. Manual therapy interventions seek to restore upper cervical mobility through a wide range of therapeutic procedures including mobilization and manipulation techniques. Previous systematic reviews reported preliminary evidence for the application of upper cervical manual therapy techniques for the management of CEH. [5] [6] [7] Although severe harm to the patient after cervical manual therapy procedures is extremely rare, [8] [9] [10] [11] [12] there is international discussion regarding the adoption of safety measures for manual techniques on the cervical spine.
To guide the assessment and treatment of the cervical spine region focusing on techniques occurring in end-range positions, notably during passive joint mobilization and manipulation, international frameworks have been developed. 13 Upper cervical translatoric spinal mobilization (UC-TSM) techniques have been suggested as a safe alternative that meets international criteria. Translatoric spinal mobilization (TSM) is defined as a system of manual techniques using straight-line forces delivered in a parallel or perpendicular direction to an individual vertebral joint or motion segment. 14 The body of evidence supporting the clinical effectiveness [15] [16] [17] [18] and safety 19, 20 of TSM in the management of patients with cervical impairments has been increasing recent years. Nevertheless, to the best of the authors' knowledge, no study to date has investigated the immediate effects of UC-TSM in patients with CEH. Therefore, the purpose of this randomized controlled trial was to evaluate immediate effects of UC-TSM on cervical mobility and cervical pressure pain thresholds (PPTs) in patients with CEH. The hypothesis was that UC-TSM produces an increase in cervical mobility and PPT in CEH patients.
METHODS
The study design was a 2-group (parallel) randomized controlled trial with pre-and post-intervention measurements. The allocation ratio was 1:1. The study was conducted in accordance with the Declaration of Helsinki and approved by the local ethics committee (Comité Ético de Investigación Clínica de Aragón). All participants provided informed consent before their enrollment in the study. This clinical trial was carried out in the facilities of the Faculty of Health Sciences, University of Zaragoza, Spain (clinicaltrials.gov number: NCT02422862).
Participants
A convenience sample of 82 volunteers (20 male, 62 female), aged 18-80 years, participated in the clinical trial (Fig 1) . The inclusion criteria were age N18 years of age and present a diagnosis of CEH according to Sjaastad et al: subjects had to fulfill both parts I and III of the major criteria (pain aggravated by neck movement, sustained position or external pressure, restricted cervical range of motion, and unilateral pain starting in the neck and radiating to the frontotemporal region). 21 These criteria have moderate to good reliability. 22 Anesthetic blockades were not used as a criterion for CEH, as the procedure was considered too invasive and is not readily accessible to most clinicians. Participants were excluded if they had received cervical treatment in the previous month, presented red flags for headache or any contraindications to manual therapy, or were currently involved in compensations. 
Procedure/Study Protocol
Participants were randomly allocated to the control (n = 41) and treatment (UC-TSM) (n = 41) groups using a computer-generated sequence of numbers (simple randomization) using Microsoft Excel 2010 performed by an independent blinded investigator. A second researcher assigned an intervention group to each number. To implement the random allocation sequence, sequentially numbered opaque sealed envelopes was used. Participants were recruited by a different researcher who was blinded to the number sequence and intervention assignment. The researcher who had to apply the manual treatment was the 1 that opened the opaque sealed envelope.
Measurements
The primary outcome measures reported in this study were cervical mobility and cervical PPT. Headache intensity was also used as secondary outcome measure.
Physical tests of the cervical spine included active cervical movements in all cardinal planes for the assessment of general cervical mobility and the flexion-rotation test (FRT) for the assessment of upper cervical mobility. For active tests, subjects were asked to move their head as far as they could without pain. 23 The FRT, which has been reported to be a valid and reliable measurement of upper cervical movement, predominantly at C1-2, was performed with the patient supine according to a method previously described by Hall et al and Takasaki et al. 24, 25 The CROM device (Pastimo Airguide, Buffalo Groove, Illinois) was used to measure cervical mobility. The CROM device is a reliable and valid method for measuring active and passive cervical mobility. 26 Three measurements of each movement were performed, and the mean was used for further analysis.
Cervical PPT was measured using a digital algometer (Somedic SenseLab AB, Farsta, Sweden) with a round surface area of 1 cm 2 , with pressure applied at the rate of 1 kg/cm 2 /s perpendicular to the skin. With the subject supine, PPT was assessed over 3 points bilaterally: upper trapezius muscle, C2-3 zygapophyseal joint, and suboccipital muscles. Patients were instructed to press the button of the digital algometer at the precise moment that pressure sensation changed to pain. The mean of 3 trials was calculated over each point and used for analysis. The reliability of PPT measurement has been found to be high (intraclass correlation coefficient = 0.91-0.97). 27, 28 Finally, current headache intensity was rated on a visual analog scale (VAS), a valid and reliable tool for measuring pain intensity widely used for pain-related research. 29, 30 A continuous vertical line of 10 cm, anchored by 2 verbal descriptors ("no pain" and "worst imaginable pain"), 1 for each extreme, was used. It has been reported that the minimal clinically important difference (MCID) in VAS depends on baseline pain score, increased with increasing baseline pain score. 31 Although a 1-to 2-point difference at the pre-and post-measures is generally considered for the MCID on a VAS, 32, 33 this varies with the baseline pain score (ie, the value increases with higher baseline pain score). 31 For low baseline VAS scores, the MCID for improvement is about 0.7 unit. 31 Two investigators with orthopedic manual therapyspecialized training and more than 5 years of experience, performed the outcome measures before and immediately after the intervention and were blinded to the allocation group of each patient throughout the process. Participants were not informed of the assignment group.
Intervention
The UC-TSM group received a 30-minute treatment consisting of 30-second series of translatoric mobilizations of the upper cervical spine with 10-second rest periods between sets. For that purpose, the patient was positioned supine, with the cervical spine in neutral position (Fig 2) . The therapist placed a hand dorsally at the level of the vertebral arch of C1 with the metacarpophalangeal and radial border of the index finger. The other hand was placed posteriorly under the occiput, with the shoulder positioned anteriorly on the patient's forehead. The mobilization force was directed dorsally from the shoulder until the therapist felt a marked resistance, and then slightly more pressure was applied to perform a stretching mobilization. No pain was reported by the subjects during the intervention. The control group received no treatment intervention, remaining supine for 30 minutes (a position and time similar to those for the UC-TSM group).
The treatment was applied by 1 therapist with orthopedic manual therapy-specialized training and more than 5 years of manual therapy experience.
Statistical Analysis
Statistical analysis was conducted with the SPSS 15.0 package (IBM, Armonk, New York). The mean and standard deviation were calculated for each variable. The KolmogorovSmirnov test was used to determine a normal distribution of quantitative data (P N .05). Intragroup and intergroup differences were analyzed using Student t test. For the variables that did not follow a Gaussian distribution, nonparametric analysis was carried out for statistical evaluation using the Mann-Whitney U test and Wilcoxon signed-rank test. Because of the convenience sample of 82 participants, effect sizes were calculated using Cohen's d coefficient. 34 An effect size N 0.8 was considered large; around 0.5, moderate; and b 0.2, small. 34 All subjects enrolled originally were included in the final analysis as planned (no participant was excluded or dropped out). Thus, participants were analyzed as per protocol (ie, by intention-to-treat). The level of significance was set at P b .05.
RESULTS
From January 2014 to October 2015, 162 volunteers were recruited. Eighty-two participants (20 male and 62 female; 41.54 years, SD = 15.29 years) satisfied all the eligibility criteria and agreed to participate. Forty-one subjects were randomly assigned to each group, received the intended treatment, and were analyzed with respect to outcome. The patients' demographic characteristics are summarized in Table 1 . There were no significant differences between the 2 groups (P N .05) at the pretreatment measurement, so it could be assumed that the 2 groups were comparable in all variables (Table 1) .
General CROM
A significant increase in general cervical range of motion was observed immediately after the intervention for the UC-TSM group in extension (P = .004), left side-bending (P = .004), right rotation (P = .016), left rotation (P b .001), and total range of movement (P = .002); however, pre-post effect sizes were small (d b 0.20) ( Table 2 ). In contrast, the control group had a significant reduction in general cervical range of movement between pre-and post-intervention measurements for flexion (P b .001) and total range of movement (P = .030) ( Table 2 ). The UC-TSM group experienced significant increases in cervical range of movement as compared with the control group in flexion (P = .012), left rotation (P = .022), and total range of movement (P = .043) ( Table 2) . Between-group effect sizes were moderate (0.33 b d b 0.56) after the intervention.
Upper CROM
A significant increase in upper CROM was observed immediately after the intervention for the UC-TSM group in the FRT (P b .001) ( Table 3) . Pre-post effect sizes were large (d = 0.81-0.85) for the UC-TSM group. For the control group, there were no statistically significant differences between pre-and post-intervention measurements (Table 3 ). The UC-TSM group experienced significant increases in upper CROM as compared with the control group in the FRT to the right (P = .006) and left (P b .001) ( Table 3) . Between-group effect sizes were considered moderate to large (d = 0.74-0.92) after the intervention.
Pressure Pain Threshold
Immediately after the treatment, there were no statistically significant differences between groups in PPT (P = .053-.610) ( Table 4 ). There were no statistically significant changes in PPT between pre-and post-intervention measurements in the UC-TSM group (d = 0.01-0.12) or in the control group (d = 0.00-0.03), except for a significant decline in left upper trapezius PPT in the control group (P = .012, d = 0.12) ( Table 4) .
Current Headache Intensity
Immediately after treatment, current headache intensity was significantly lower in the UC-TSM group (P = .039) ( Table 4) . Between-group effect size was large (d = 1.26) after the intervention. The UC-TSM group reduced current headache intensity 0.58 (SD = 1.99), from 1.31 (SD = 2.25) to 0.72 (SD = 1.19), with a moderate pre-post effect size (d = 0.57) ( Table 4) . In contrast, the control group increased 0.45 (SD = 0.72), from 1.58 (SD = 2.13) to 2.02 (SD = 2.40) ( Table 4) .
No harm or unintended effect derived from the intervention was reported.
DISCUSSION
This study indicated that a single session of UC-TSM resulted in an immediate increase of upper cervical range in patients with CEH.
Evidence for Cervical Mobility Changes Following Cervical Manual Therapy Interventions
The present study found that UC-TSM may be effective for an improvement in general and upper cervical mobility in subjects with CEH. The UC-TSM group had a statistically significant increase in general cervical mobility; however, effect sizes were small and in no case reached the minimal detectable change. 35 Nevertheless, because of the involvement of the upper cervical spine in CEH, especially the C1-2 segment, 36 quantification of upper cervical mobility is more important in the assessment of CEH patients. The FRT is supposed to be a valid and reliable tool for testing C1-2 mobility. 24, 25 In the present study, increases in the FRT in the UC-TSM group exceeded the minimal detectable change, 37 reaching the clinically relevant improvement for patients with CEH, 38 unlike in the control group, in which there was reduced FRT mobility. The improvement in FRT mobility obtained in the present study in response to UC-TSM with the cervical spine in neutral position are comparable to those of previous studies using different cervical manual techniques applied at the end of the cervical rotation, in asymptomatic subjects 39 and patients with neck pain 40 or CEH. 41 These findings support the efficacy of UC-TSM in increasing upper cervical mobility, suggested as a technique in neutral cervical position meeting the international recommendations. 13 Based on the available evidence, these results can be explained by a model in which a mechanical input generated by the UC-TSM triggers a cascade of biomechanical and neurophysiologic events, leading to an increase in cervical mobility. 42 
Evidence for Hypoalgesic Changes Following Cervical Manual Therapy Interventions
The present study found that the UC-TSM group did not exhibit significant changes in PPT. This result contrasts with previous studies that reported an increase in cervical PPT after UC-TSM in patients with cervical 43 and craniofacial 44 pain. Differences in the sample or in the treatment dose could explain these controversial findings, and should be taken into consideration in future studies.
Analysis of headache intensity revealed that UC-TSM may be effective for an immediate reduction of headache intensity in patients with CEH, as reported for other manual therapy techniques. [45] [46] [47] [48] [49] [50] Nevertheless, the pain reduction, although statistically significant (P b .05) and with large effect size (d N 0.8), was small (close to 0.5 on the VAS). The results of the present study should be interpreted with caution. Results for headache intensity did not reach the recommended MCID on the VAS of 1-2 points. 32, 33 Nonetheless, some have argued that the MCID value varies depending on baseline pain score, with the MCID increasing for higher baseline pain score. 31 In case of low baseline scores as in the current study (mean baseline headache intensity of about 1.5), a difference of 0.5 may be considered a clinically relevant change. 51 In any case, the results of the present study in terms of headache intensity should be interpreted with caution, taking into account the considerations previously described. On the other hand, to the best of the authors' knowledge, no study has investigated immediate effects on current headache intensity in CEH. Most studies recorded headache intensity based on episodes experienced in the preceding week or month. [45] [46] [47] [48] [49] [50] Current evidence suggests that the immediate hypoalgesic effects of manual therapy may be due to the neurophysiologic mechanisms activated, in this case, by the mechanical stimulus of the UC-TSM. 52, 53 Possible neurophysiologic mechanisms include the activation of descendant pain inhibitory systems via corticospinal projections from the periaqueductal gray matter. [54] [55] [56] [57] [58] Further studies are needed to determine the mechanisms of hypoalgesic effects of manual therapy interventions in CEH patients.
Limitations
Although a potential strength of the current controlled clinical trial was the inclusion of a control group that did not receive any intervention, we should recognize potential limitations. First, headache intensity during the procedure was low in both groups (VAS = 1.31 and 1.58), hindering meaningful interpretations of headache intensity results because of the occurrence of a floor effect. For this reason, headache intensity was not used as a main study variable. Additionally, this study presents immediate effects of UC-TSM, so short-and long-term effects should not be inferred. Third, the control group did not receive any type of intervention, so a placebo effect cannot be ruled out. Significant differences observed in the control group (increase in VAS and reduction in total cervical ROM) should be considered when interpreting results. One possibility observed during field work is that the evaluation tests used (especially algometry for PPTs) may have irritated participants, increasing their pain and reducing their cervical mobility, which would highlight the improvements achieved in the intervention group. However, the authors have to admit that these differences could be the explanation for between-group changes obtained in the present study or could indicate that the condition is evolving randomly. These aspects especially must be taken into account, and results should be interpreted with great caution. Furthermore, because of clinical conditions, a convenience sample of 82 consecutive patients was used, but no sample size calculation was performed. The results of the present study should be interpreted in consideration of this issue, and future studies should consider an adequate sample size. On the other hand, 1 therapist provided the treatment in the current study, which may limit the generalization of the results. Finally, CEH subject selection was based on clinical criteria; however, anesthetic blockades were not used as a criterion. Further studies should address these issues.
Further research considering the limitations of the present clinical trial is required to confirm the tendency to an immediate increase in general cervical range mobility and a reduction in headache intensity in patients with CEH.
